Catalog No.
DXX02101
Expression system
Mammalian Cells
Species reactivity
P. aeruginosa
Host species
Human
Isotype
IgM-kappa
Clonality
Monoclonal
Target
LPS
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Applications
Research Grade Biosimilar
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names
Lambrolizumab, Aerumab 11, KBPA101, CAS: 885053-97-4
Clone ID
Panobacumab
Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia, PMID: 24859907
The anti-Pseudomonas aeruginosa antibody Panobacumab is efficacious on acute pneumonia in neutropenic mice and has additive effects with meropenem, PMID: 24023870
Anti-Pseudomonas aeruginosa serotype O11 LPS immunoglobulin M monoclonal antibody panobacumab (KBPA101) confers protection in a murine model of acute lung infection, PMID: 21393169
Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia, PMID: 21398296
Gateways to clinical trials, PMID: 20140276
Development of a 4-valent genotyping assay for direct identification of the most frequent Pseudomonas aeruginosa serotypes from respiratory specimens of pneumonia patients, PMID: 24430251
6th Annual European Antibody Congress 2010: November 29-December 1, 2010, Geneva, Switzerland, PMID: 21441785
For research use only. Not for human or drug use.
